HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tissue factor associates with survival and regulates tumour progression in osteosarcoma.

Abstract
Osteosarcoma is the most common primary malignant bone tumour. Patients often develop lung metastasis and have a poor prognosis despite extensive chemotherapy and surgical resections. Tissue Factor is associated with poor clinical outcome in a wide range of cancer types, and promotes angiogenesis and metastasis. The role of Tissue Factor in OS tumourigenesis is unknown. Fifty-three osteosarcoma pre-treatment biopsies and four osteosarcoma cell lines were evaluated for Tissue Factor expression, and a possible association with clinical parameters was investigated. Tissue Factor function was inhibited in an osteosarcoma cell line (143B) by shRNA knockdown or specific antibodies, and pro-tumourigenic gene expression, proliferation, matrigel invasion and transwell migration was examined. 143B cells were implanted in mice in the presence of Tissue Factor-blocking antibodies, and tumour volume, micro-vessel density and metastases in the lung were evaluated. Tissue Factor was highly expressed in 73.6 % of osteosarcoma biopsies, and expression associated significantly with disease-free survival. Tissue Factor was expressed in all four investigated cell lines. Tissue Factor was knocked down in 143B cells, which led to reduced expression of IL-8, CXCL-1, SNAIL and MMP2, but not MMP9. Tissue Factor knockdown or inhibition with antibodies reduced matrigel invasion. Tissue Factor antibodies limited 143B tumour growth in vivo, and resulted in decreased intra-tumoural micro-vessel density. Furthermore, lung metastasis from the primary tumour was significantly reduced. Thus, Tissue Factor expression in osteosarcoma reduces metastasis-free survival in patients, and increases pro-tumourigenic behaviour both in vitro and in vivo.
AuthorsChris Tieken, Michiel C Verboom, Wolfram Ruf, Hans Gelderblom, Judith V M G Bovée, Pieter H Reitsma, Anne-Marie Cleton-Jansen, Henri H Versteeg
JournalThrombosis and haemostasis (Thromb Haemost) Vol. 115 Issue 5 Pg. 1025-33 (05 02 2016) ISSN: 2567-689X [Electronic] Germany
PMID26763081 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • RNA, Messenger
  • RNA, Neoplasm
  • Thromboplastin
Topics
  • Adolescent
  • Animals
  • Bone Neoplasms (genetics, metabolism, pathology)
  • Cell Line, Tumor
  • Cell Movement
  • Cell Proliferation
  • Child
  • Disease-Free Survival
  • Female
  • Gene Expression
  • Gene Knockdown Techniques
  • Humans
  • Male
  • Mice, Inbred NOD
  • Mice, SCID
  • Neoplasm Invasiveness
  • Osteosarcoma (genetics, metabolism, pathology)
  • RNA, Messenger (genetics, metabolism)
  • RNA, Neoplasm (genetics, metabolism)
  • Thromboplastin (antagonists & inhibitors, genetics, metabolism)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: